FAGGIAN, DAVIDE
FAGGIAN, DAVIDE
Analytical evaluation of the new Beckman Coulter access procalcitonin (PCT) chemiluminescent immunoassay
2020 Lippi, G.; Salvagno, G. L.; Gelati, M.; Pucci, M.; Demonte, D.; Faggian, D.; Plebani, M.
Analytical performances of a chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG and antibody kinetics
2020 Padoan, A.; Cosma, C.; Sciacovelli, L.; Faggian, D.; Plebani, M.
Basal and Calcium-Stimulated Procalcitonin for the Diagnosis of Medullary Thyroid Cancers: Lights and Shadows
2021 Censi, S.; Di Stefano, M.; Repaci, A.; Benvenuti, T.; Manso, J.; Pagotto, U.; Iacobone, M.; Barollo, S.; Bertazza, L.; Galuppini, F.; Benna, C.; Pennelli, G.; Plebani, M.; Faggian, D.; Colombo, C.; Fugazzola, L.; Mian, C.
Can ultrasensitive thyroglobulin immunoassays avoid the need for ultrasound in thyroid cancer follow-up?
2021 Censi, S.; De Rosa, A.; Galuppini, F.; Manso, J.; Bertazza, L.; Merante-Boschin, I.; Plebani, M.; Faggian, D.; Pennelli, G.; Barollo, S.; Vianello, F.; Iacobone, M.; Mian, C.
IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: A longitudinal study
2020 Padoan, A.; Sciacovelli, L.; Basso, D.; Negrini, D.; Zuin, S.; Cosma, C.; Faggian, D.; Matricardi, P.; Plebani, M.
Pharmacological closure of patent ductus arteriosus: Effects on pulse pressure and on endothelin-1 and vasopressin excretion
2008 Zanardo, V.; Vedovato, S.; Chiozza, L.; Faggian, D.; Favaro, F.; Trevisanuto, D.
Serum miR-375 for Diagnostic and Prognostic Purposes in Medullary Thyroid Carcinoma
2021 Censi, S.; Bertazza, L.; Piva, I.; Manso, J.; Benna, C.; Iacobone, M.; Mondin, A.; Plebani, M.; Faggian, D.; Galuppini, F.; Pennelli, G.; Barollo, S.; Mian, C.